NL-OMON55389招募中不适用
Establishing organoids from metastatic pancreatic cancer patients, the OPT-I study - OPT-I
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients older than 18 years
- •- Diagnosed with locally advanced pancreatic cancer or metastatic pancreatic
- •- Able to understand the information given
- •- WHO 0-2
排除标准
- •- Unfit for biopsies & blood analyses in palliative chemotherapy studies
- •- Not able to give informed consent (language, intellectual capacities, etc.)
研究者
相似试验
Unknown
不适用
Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.Carcinoma, Pancreatic DuctalNCT03500068Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)30
终止
1 期
Investigation of gemcitabine combined with temsirolimus, in patients with inoperable or metastatic pancreatic cancer. A phase I-II study by the Hellenic Cooperative Oncology Group with biomarker evaluation (HE3/07)Patients with inoperable or metastatic pancreatic cancerCancer - PancreaticACTRN12611000643976Hellenic Cooperative Oncology Group85
已完成
不适用
Patient-derived Organoids Drug Screen in Pancreatic CancerPancreas CancerPancreas NeoplasmPancreas AdenocarcinomaPancreatic NeoplasmsPancreatic AdenocarcinomaPancreatic CancerNCT05351983Prof. Dr. med. Dres. h.c. Jan Schmidt, MME60
已完成
不适用
Development of cytological analysis of pancreatic cancer using homology technologypancreatic cancerJPRN-UMIN000044462Mie University180
尚未招募
不适用
Botulinum toxin (BOTOX®) to prevent post-operative pancreatic fistula in patients who undergo distal pancreatectomy. (PROFIT study)Pancreatic cancerNL-OMON22900Erasmus MC50